• News
  • BioTech

Cardium announces positive data for heart disease treatment

Taxus Cardium Pharmaceuticals Group Inc. will report Tuesday at the 2014 BIO International Convention on its clinical study of Cardium Therapeutics' angiogenic gene therapy product candidate for patients with myocardial ischemia due to coronary artery disease.

To continue reading, subscribe now
log in to your account
User Response
0 UserComments
Subscribe Today!